Page last updated: 2024-11-06

zotepine and Dyskinesia, Drug-Induced

zotepine has been researched along with Dyskinesia, Drug-Induced in 7 studies

zotepine: structure

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research Excerpts

ExcerptRelevanceReference
"Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks."9.09A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000)
"Patients with acute exacerbation of schizophrenia (DSM-III-R criteria; n = 158) were allocated on a random, double-blind basis to receive zotepine (150 or 300 mg/day), chlorpromazine (300 or 600 mg/day) or placebo for 8 weeks."5.09A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. ( Butler, A; Cooper, SJ; Raniwalla, J; Tweed, J; Welch, C, 2000)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, CC1
Bai, YM1
Chen, JY1
Wang, YC1
Liou, YJ1
Arnold, G1
Trenkwalder, C1
Schwarz, J1
Oertel, WH1
Cooper, SJ1
Tweed, J1
Raniwalla, J1
Butler, A1
Welch, C1
Naber, D1
Möller, HJ1
Fleischhacker, WW2
Barnas, C2
Stuppäck, CH2
Sperner-Unterweger, B2
Miller, C2
Hinterhuber, H1
Haring, C1

Reviews

1 review available for zotepine and Dyskinesia, Drug-Induced

ArticleYear
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
    Der Nervenarzt, 2000, Volume: 71, Issue:5

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins;

2000

Trials

3 trials available for zotepine and Dyskinesia, Drug-Induced

ArticleYear
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Acta psychiatrica Scandinavica, 2000, Volume: 101, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Dibenzothiepins; Dose-Respon

2000
[Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
    Fortschritte der Neurologie-Psychiatrie, 1991, Volume: 59 Suppl 1

    Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Female;

1991
[Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Fortschritte der Neurologie-Psychiatrie, 1991, Volume: 59 Suppl 1

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug

1991

Other Studies

3 other studies available for zotepine and Dyskinesia, Drug-Induced

ArticleYear
Treatment of clozapine-associated tardive dyskinesia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2

    Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Clozapine; Cross-Over Studies; Dibenzothiepins;

2008
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiepins; Dose-Response Relationship, Drug;

1994
[Atypical antipsychotics].
    Der Nervenarzt, 2000, Volume: 71, Issue:5

    Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis;

2000